Found: 24
Select item for more details and to access through your institution.
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma.
- Published in:
- Journal of Oncology, 2018, p. 1, doi. 10.1155/2018/1908065
- By:
- Publication type:
- Article
Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 842, doi. 10.1007/s10637-017-0476-6
- By:
- Publication type:
- Article
Erratum to: Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 4, p. 436, doi. 10.1007/s10637-017-0464-x
- By:
- Publication type:
- Article
Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1427, doi. 10.1002/ajh.27339
- By:
- Publication type:
- Article
Pembrolizumab for Unresectable or Metastatic Melanoma in Patients Older than 85 Years of Age.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune Activation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Infliximab in recalcitrant granuloma annulare.
- Published in:
- International Journal of Dermatology, 2016, v. 55, n. 2, p. 220, doi. 10.1111/ijd.12458
- By:
- Publication type:
- Article
Infliximab in recalcitrant granuloma annulare.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 6, p. 1, doi. 10.1111/ijd.12458
- By:
- Publication type:
- Article
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3547, doi. 10.3390/cancers13143547
- By:
- Publication type:
- Article
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 931, doi. 10.3390/cancers12040931
- By:
- Publication type:
- Article
Uveitis in Patients With Late-Stage Cutaneous Melanoma Treated With Vemurafenib.
- Published in:
- JAMA Ophthalmology, 2014, v. 132, n. 12, p. 1421, doi. 10.1001/jamaophthalmol.2014.3024
- By:
- Publication type:
- Article
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 11, p. 1926, doi. 10.1002/ijc.33746
- By:
- Publication type:
- Article
Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity.
- Published in:
- Brain Communications, 2023, v. 5, n. 3, p. 1, doi. 10.1093/braincomms/fcad169
- By:
- Publication type:
- Article
Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1866, doi. 10.1038/s41416-024-02659-x
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated Melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).
- Published in:
- Oncologist, 2024, v. 29, n. 10, p. e1364, doi. 10.1093/oncolo/oyae145
- By:
- Publication type:
- Article
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. e1180, doi. 10.1093/oncolo/oyae085
- By:
- Publication type:
- Article
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article